Biotech | July 07, 2025
Godavari Biorefineries' anti-cancer patent now validated in Spain and UK
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Adjusted Profit After Tax (PAT) for the year ended March 31, 2025 was at Rs. 1,389.4 crore
Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30%
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
Subscribe To Our Newsletter & Stay Updated
